Nurix Therapeutics : Anticipate Sharing Additional Clinical Data About Ongoing Phase 1B Expansion Cohort in 2025
- Latest
- Detail
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
07:34
GTJA: The centralized procurement of Chinese Patent Medicine is still in the early stages, and quality improvement and expansion are expected to continue to progress.
Guotai Junan-0.11%
07:33
In Japan, nominal overall cash earnings of employees in November increased by 3.3% compared to the same period last year. In November, real wages adjusted for inflation in Japan decreased by 0.3% compared to the same period last year.
07:32
The SGX Nikkei/Yen Futures opened down 60 points at 39,895 points.
SGX+0.40%